Search research articles
Contact Us
Filters
Showing results (551-560 of 889) with videos related to
Page
of 89
Sort By:
Journal of the American Academy of Dermatology
|
February 6, 2008
Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
Shanu Kohli Kurd, Nana Smith, Abby VanVoorhees, et al.
Journal of Embryology and Experimental Morphology
|
November 1, 1970
Effect of colcemid on the locomotory behaviour of fibroblasts
J M Vasiliev, I M Gelfand, L V Domnina, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 21, 2023
Neuropsychiatric disorders in adults with atopic dermatitis: A population-based cohort study
Joy Wan, Sonia Wang, Daniel B Shin, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
March 27, 2025
No evidence of fluctuations in daily step count between infusions in people with multiple sclerosis treated with anti-CD20 monoclonal antibodies
Valerie J Block, Kyra Henderson, Shane Poole, et al.
American Journal of Preventive Medicine
|
March 19, 2013
Psoriasis and psoriatic arthritis: a public health agenda
Charles G Helmick, Jeffrey J Sacks, Joel M Gelfand, et al.
The American Journal of Medicine
|
July 27, 2011
Attributable risk estimate of severe psoriasis on major cardiovascular events
Nehal N Mehta, YiDing Yu, Rebecca Pinnelas, et al.
Archives of Dermatology
|
June 20, 2012
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis
Rahat S Azfar, Nicole M Seminara, Daniel B Shin, et al.
Journal of the American Academy of Dermatology
|
March 18, 2026
Reply to Woodie, et al., "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX."
Tiago Torres, Andrew Blauvelt, Bruce Strober, et al.
Archives of Dermatology
|
February 22, 2012
A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men
Joy Wan, Carmela C Vittorio, Katrina Abuabara, et al.
Rheumatology (Oxford, England)
|
February 4, 2017
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis
Alexis Ogdie, Samantha Maliha, Daniel Shin, et al.
Page
of 89
Search research articles
Search
Showing results (551-560 of 889) with videos related to
Sort By:
Page
of 89
Journal of the American Academy of Dermatology
|
February 6, 2008
Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
Shanu Kohli Kurd, Nana Smith, Abby VanVoorhees, et al.
Journal of Embryology and Experimental Morphology
|
November 1, 1970
Effect of colcemid on the locomotory behaviour of fibroblasts
J M Vasiliev, I M Gelfand, L V Domnina, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 21, 2023
Neuropsychiatric disorders in adults with atopic dermatitis: A population-based cohort study
Joy Wan, Sonia Wang, Daniel B Shin, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
March 27, 2025
No evidence of fluctuations in daily step count between infusions in people with multiple sclerosis treated with anti-CD20 monoclonal antibodies
Valerie J Block, Kyra Henderson, Shane Poole, et al.
American Journal of Preventive Medicine
|
March 19, 2013
Psoriasis and psoriatic arthritis: a public health agenda
Charles G Helmick, Jeffrey J Sacks, Joel M Gelfand, et al.
The American Journal of Medicine
|
July 27, 2011
Attributable risk estimate of severe psoriasis on major cardiovascular events
Nehal N Mehta, YiDing Yu, Rebecca Pinnelas, et al.
Archives of Dermatology
|
June 20, 2012
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis
Rahat S Azfar, Nicole M Seminara, Daniel B Shin, et al.
Journal of the American Academy of Dermatology
|
March 18, 2026
Reply to Woodie, et al., "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX."
Tiago Torres, Andrew Blauvelt, Bruce Strober, et al.
Archives of Dermatology
|
February 22, 2012
A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men
Joy Wan, Carmela C Vittorio, Katrina Abuabara, et al.
Rheumatology (Oxford, England)
|
February 4, 2017
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis
Alexis Ogdie, Samantha Maliha, Daniel Shin, et al.
Page
of 89